Invention Grant
- Patent Title: Vaccine
- Patent Title (中): 疫苗
-
Application No.: US12440054Application Date: 2007-09-07
-
Publication No.: US08945582B2Publication Date: 2015-02-03
- Inventor: Herve De Hemptinne , Michel Duchene , Anne Mary , Marc Sonveaux
- Applicant: Herve De Hemptinne , Michel Duchene , Anne Mary , Marc Sonveaux
- Applicant Address: BE Rixensart
- Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee: GlaxoSmithKline Biologicals S.A.
- Current Assignee Address: BE Rixensart
- Agent Eric J. Kron
- Priority: GB0617602.8 20060907; GB0625593.9 20061221
- International Application: PCT/EP2007/059390 WO 20070907
- International Announcement: WO2008/028956 WO 20080313
- Main IPC: A61K39/295
- IPC: A61K39/295 ; A61K39/13 ; A61K39/116 ; A61K39/00 ; A61K39/12
Abstract:
The standard dose of polio vaccines contains 40 D-antigen units of inactivated poliovirus type 1 (Mahoney), 8 D-antigen units of inactivated poliovirus type 2 (MEF-1), and 32 D-antigens units of inactivated poliovirus type 3 (Saukett). The present invention teaches that reduced doses of inactivated poliovirus can maintain adequate or improved level of protection against polio.
Public/Granted literature
- US20100034850A1 VACCINE Public/Granted day:2010-02-11
Information query
